Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Ahmed, Faruque ; Nowalk, Mary Patricia ; Zimmerman, Richard K. ; Bear, Todd ; Grijalva, Carlos G. ; Talbot, H. Keipp ; Florea, Ana ; Tartof, Sara Y. ; Gaglani, Manjusha ; Smith, Michael ; McLean, Huong Q. ; King, Jennifer P. ; Martin, Emily T. ; Monto, Arnold S. ; Phillips, C. Hallie ; Wernli, Karen J. ; Flannery, Brendan ; Chung, Jessie R. ; Uzicanin, Amra
• Description:
  Both SARS-CoV-2 and influenza virus can be transmitted by asymptomatic, presymptomatic, or symptomatic infected persons. We assessed effects on work attendance while ill before and during the COVID-19 pandemic in the United States by analyzing data collected prospectively from persons with acute respiratory illnesses enrolled in a multistate study during 2018-2022. Persons with previous hybrid work experience were significantly less likely to work onsite on the day before through the first 3 days of illness than those without that experience, an effect more pronounced during the COVID-19 pandemic than during prepandemic influenza seasons. Persons with influenza or COVID-19 were significantly less likely to work onsite than persons with other acute respiratory illnesses. Among persons with positive COVID-19 test results available by the second or third day of illness, few worked onsite. Hybrid and remote work policies might reduce workplace exposures and help reduce spread of respiratory viruses.
• Subjects:
  Research Work Attendance With Acute Respiratory Illness Before And During COVID-19 Pandemic, United States, 2018–2022
• Keywords:
  Acute Respiratory Illness Coronavirus Disease COVID-19 COVID-19 Testing Disease Transmission Humans Influenza Influenza, Human Pandemics Presenteeism Respiratory Infections SARS-COV-2 Severe Acute Respiratory Syndrome Coronavirus 2 Teleworking United States Viruses Workplaces

  More +
• Source:
  Emerg Infect Dis. 2023; 29(12):2442-2450
• Pubmed ID:
  37917142
• Pubmed Central ID:
  PMC10683820
• Document Type:
  Journal Article
• Funding:
  K24 AI148459/AI/NIAID NIH HHSUnited States/ ; UL1 TR001857/TR/NCATS NIH HHSUnited States/
• Volume:
  29
• Issue:
  12
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:460c7df3a9858c199897766e5acf8dbcea7b3a3502b55d070a4559d1d1781915
• Download URL:
  https://stacks.cdc.gov/view/cdc/138537/cdc_138537_DS1.pdf
• File Type:
  [PDF - 807.66 KB ]